Discover how WuXi AppTec's In Vitro ADME team leverages 15+ years of expertise, 200+ experimental models, and advanced technology to transform drug discovery. From permeability and metabolic stability to regulatory-compliant IND support, we strive to turn the 0.1% possibility into a reality.
Related Resources
-
Methodological Comparison of Microsomal Protein Binding: Equilibrium Dialysis, Pre‑Saturation, and Flux Dialysis for Highly Bound Compounds
PostersJun 05, 2026Learn More -
DMPK Strategies for Proteolysis-Targeting Chimeras: Addressing ADME and PK Challenges
WebinarsJun 05, 2026Learn More -
Application of Acoustic Ejection Mass Spectrometry for Plasma Protein Binding Assay Using Flux Dialysis
PublicationsApr 29, 2026Learn More -
HSA Biomimetic Chromatography: Rapid Determination of Fraction Unbound (fu) in PPB Studies for Challenging Compounds
ArticlesMar 19, 2026Learn More -
Evaluation of Time-Dependent Inhibition (TDI) of CYP3A4 by Peptide Therapeutics: A Comparison of Human Hepatocyte and Human Liver Microsome Assays
PostersJan 18, 2026Learn More -
What is Alpha-1 Acid Glycoprotein (AAG) and Its Role in Drug Binding for Pharmacokinetics and Pharmacodynamics Studies
ArticlesJan 09, 2026Learn More -
DDIM vs. TDI in CYP Enzyme Inhibition Studies: Can Results from a CYP Direct Inhibition Assay be Used to Predict Time-Dependent Inhibition Risk?
ArticlesDec 19, 2025Learn More -
Tackling the CNS Drug Challenges with DMPK Toolkit
WebinarsDec 05, 2025Learn More -
Application of Lecithin (PL90) and Poloxamer 188 in SLC Transporter-Mediated Drug Interaction Studies
PostersNov 21, 2025Learn More -
Pregnane X Receptor (PXR) in Drug Metabolism: Mechanism, Role, and HepG2-Based Screening
BlogsNov 07, 2025Learn More
Stay Connected
Keep up with the latest news and insights.
Thanks for signing up
Help us get to know you better! By customizing your email preferences, we can deliver curated content relevant to you.
-
Not Now
-
Customize Now
Thanks for signing up
Help us get to know you better! By customizing your email preferences, we can deliver curated content relevant to you.
-
Not Now
-
Customize Now